Johnson L C, Chernik D A
Psychopharmacology (Berl). 1982;76(2):101-13. doi: 10.1007/BF00435262.
In 52 studies, performance data were obtained the next day following bedtime ingestion of a sedative-hypnotic or a placebo. Only eight of these studies used insomniac patients. Most studies used young adult males. Benzodiazepine hypnotics were most frequently administered and psychomotor performance was most often measured. Little consistent data are available on cognitive functioning and more complex behavior. Drug-related improvement in performance was not found, and, in comparing active drug to placebo, it is clear that all hypnotics, at some doses, produce decrements in performance the next day. Higher doses consistently showed a decrement, and this decrement was usually persistent over the entire day. Although long-acting drugs generally showed more performance decrement, half-life data were not consistent.
在52项研究中,在睡前服用镇静催眠药或安慰剂后的第二天获取了性能数据。这些研究中只有8项使用了失眠患者。大多数研究使用的是年轻成年男性。苯二氮䓬类催眠药使用最为频繁,心理运动性能测量最为常见。关于认知功能和更复杂行为的一致数据很少。未发现与药物相关的性能改善,并且在将活性药物与安慰剂进行比较时,很明显所有催眠药在某些剂量下第二天都会导致性能下降。较高剂量始终显示出下降,并且这种下降通常在一整天内持续存在。尽管长效药物通常表现出更多的性能下降,但半衰期数据并不一致。